Close
Acticor Biotech Updates Its Glenzocimab Clinical Development Plan for the Treatment of Cardiovascular Emergencies Jun 3, 2024 12:28PM
  • New analyses of ACTISAVE phase 2/3 study show positive trends for glenzocimab in subpopulations of patients
  • Continuation of clinical studies: Phase 2/3 GREEN in Ischemic stroke and Phase 2b LIBERATE in myocardial infarction
  • Launch of GALICE, a Phase 2/3 study in severe ischemic stroke, sponsored by the Hôpital Fondation Adolphe de Rothschild and funded by a public grant (national PHRC1 in 2023)

PARIS--(BUSINESS WIRE)-- Regulatory News:

ACTICOR... (continue reading...)


PRESS RELEASE: NACON: STRONG EARNINGS GROWTH IN 2023/24 Jun 3, 2024 12:25PM

                                                Press release

Lesquin, 3 June 2024, 6pm CET

STRONG EARNINGS GROWTH IN 2023/24

  • EBITDA: €70.9 MILLION, UP 45%
  • OPERATING INCOME: €20.9 MILLION, UP 20.5%
  • NET INCOME: €17.5 MILLION, UP 37.3%

2024/25: CONTINUING GROWTH IN BUSINESS LEVELS AND OPERATING INCOME

NACON (ISIN FR0013482791) is today announcing consolidated results for its 2023/24 financial year (from 1 April 2023 to 31 March 2024) as... (continue reading...)


Gecina: Monthly Disclosure of the Total Number of Shares and Voting Rights Jun 3, 2024 12:25PM

(In conformity with the article 223-16 of the general regulation of AMF (Autorité des Marchés Financiers)

PARIS--(BUSINESS WIRE)--

Regulatory News:

Gecina (Paris: GFC):

Date

Total number of shares

Total number of voting rights

May 2024

 76,670,861

Total number of voting rights

(including treasury shares):

76,670,861

 

 

Total number of voting rights

(excluding treasury shares):

... (continue reading...)


HCSG Provides Update On Client Restructuring; Reiterates 2024 Cash Flow Forecast & ROY Outlook Jun 3, 2024 12:25PM

BENSALEM, Pa.--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ: HCSG) today issued the following statement in response to LaVie Care Centers’ announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Georgia. As a result of LaVie’s filing, the Company estimates a Q2 non-cash charge of approximately $0.20 per share. The Company expects to continue providing services to LaVie and expects no impact on future revenue... (continue reading...)


Significant Results From Diamond Drilling at Belltopper, Victoria Jun 3, 2024 12:24PM

HIGHLIGHTS

  • A six-hole, 2,529 m, diamond drill program has been completed at the Belltopper Gold Project in Victoria.
  • Significant intercepts include:
    • 5.6 m @ 3.14 g/t Au from 219.8 m and 4.25 m @ 5.88 g/t Au from 274.75 m (including 2 m @ 11.15 g/t Au) and 1.94 m @ 2.37 g/t Au from 230 m in BTD001 on the Leven Star Reef.
    • 2 m @ 15.18 g/t Au from 9 m in BTD004 on a newly discovered reef.
    • 12.26 m @ 1.45 g/t Au from 185 m (including 4.6 m @... (continue reading...)

More Press Releases

View Older Stories

Jun 3, 2024 12:24PM Significant Results From Diamond Drilling at Belltopper, Victoria
Jun 3, 2024 12:23PM Optimove to Highlight Data Extensions, its Latest Advancement to its Customer-Led Marketing Platform, at the 2024 Gartner® Marketing Symposium| Xpo™ in Denver, June 3-5
Jun 3, 2024 12:21PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
Jun 3, 2024 12:20PM The Human Bean Announces Giveback Partnership with St. Jude Children's Research Hospital®
Jun 3, 2024 01:18PM Benefits Of Moveon Joint Supplements And Liveon Supplements
Jun 3, 2024 12:19PM June is Automotive Service Professionals Month
Jun 3, 2024 12:18PM Mexicana de Aviación Orders 20 Embraer E2 Aircraft
Jun 3, 2024 12:16PM Kirby McInerney LLP Reminds Lincoln National Corporation (LNC) Investors of Class Action Filing and Encourages Investors to Contact the Firm
Jun 3, 2024 12:15PM Marcum Technology Announces Strategic Acquisition of CLA's IT Enhanced Managed Services Division
Jun 3, 2024 12:15PM Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies
Jun 3, 2024 12:15PM BGHL (GBP): Estimated NAV(s)
Jun 3, 2024 12:15PM BGHL (EUR): Estimated NAV(s)
Jun 3, 2024 12:14PM American Humane Kicks Off 14th Annual Hero Dog Awards
Jun 3, 2024 12:13PM Blank Rome Welcomes Leading Maritime Partner Luke Reid in Boston
Jun 3, 2024 12:11PM Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Jun 3, 2024 12:08PM WGU Receives CCNE Accreditation for 10 Years
Jun 3, 2024 12:08PM Opto Investments Establishes Strategic Partnership with Mercer Advisors to Reinvent Clients’ Private Markets Experience
Jun 3, 2024 12:07PM Century Communities Now Selling Affordable New Homes in Ferris, TX
Jun 3, 2024 12:05PM JanOne Inc. added to the Russell Microcap® Index
Jun 3, 2024 12:04PM KBRA Assigns Preliminary Ratings to Mercury Financial Credit Card Master Trust Series 2024-2
Jun 3, 2024 12:04PM SoFi Appoints Stephen Simcock as General Counsel
Jun 3, 2024 12:03PM HF Fund: Auction in connection with the sale of bonds in series LSS150434
Jun 3, 2024 12:00PM Liberty Tax Seeks New Franchise Partners
Jun 3, 2024 12:02PM ALK launches new growth strategy and 2028 financial ambitions
Jun 3, 2024 12:00PM Sesame Workshop’s 21st Annual Benefit Celebrates the Life-Changing Power of Early Education, Honoring Shonda Rhimes and PNC Financial Services Group
Jun 3, 2024 12:00PM Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise
Jun 3, 2024 12:01PM Solutionreach Unveils Revolutionary All-in-One Insurance Eligibility Technology
Jun 3, 2024 12:01PM Device Refresh Cycles and the Emergence of AI PCs are Forecast to Drive Modest PC Growth in 2024, According to IDC
Jun 3, 2024 12:00PM Travefy CEO David Chait Joins the Travel Institute Board of Directors
Jun 3, 2024 12:00PM OKI Signs Partnership Agreement with US-based Plug and Play
Jun 3, 2024 12:00PM J.C. Flowers Completes Sale of First Bank Romania
Jun 3, 2024 12:00PM CareConnect's AI-Powered Workforce Optimization Platform is a Transformative Addition to the Home Care and Post-Acute Care Industries
Jun 3, 2024 12:00PM ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Operating Officer
Jun 3, 2024 12:00PM Databricks Releases Keynote Lineup and Data Intelligence Programming for 2024 Data + AI Summit
Jun 3, 2024 12:00PM Impress Communications recognized for "Environmentally Sound" packaging at the 2024 PIASC Awards
Jun 3, 2024 12:00PM amazee.io Achieves SOC 2 Type 2 Attestation
Jun 3, 2024 12:00PM Housing Affordability Is Gen Z’s Top Voting Issue, Outweighing Abortion Rights and the Economy: Redfin Survey
Jun 3, 2024 12:00PM Gold Nugget Judges Honor Legacy Square, Designed by SVA Architects, with Two Awards of Merit
Jun 3, 2024 12:00PM John Deere Helps Increase Access to Higher Ed
Jun 3, 2024 12:00PM Medincell: Publication of the Financial Results for the 2023-2024 Fiscal Year and Videoconference on Monday, June 10, 2024
Jun 3, 2024 12:00PM Skanska Appoints Brian Best to General Counsel for USA Building Operations
Jun 3, 2024 12:00PM Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform
Jun 3, 2024 12:00PM Cupshe Collaborates with 'The Bachelorette' Star JoJo Fletcher for Debut Co-Designed Collection: Soul Space
Jun 3, 2024 12:00PM American Lending Center Celebrates 15 Years Of Growth
Jun 3, 2024 12:00PM Digital Holdings Group Champions Renewable Energy in Bitcoin Mining Sector
Jun 3, 2024 12:00PM Buzbug Revolutionizes Insect Control with Launch of New UV-LED Bug Zappers in 2024
Jun 3, 2024 12:00PM CMP Scientific Launches BioSummit™ CVA System, the Next-Generation cIEF-MS Platform for Charge Variant Analysis
Jun 3, 2024 12:00PM LambdaTest Introduces Test Manager for Streamlined Test Management
Jun 3, 2024 12:00PM OKX Launches Industry's First 'Hybrid Spreads' Orderbooks for Cross-Currency Arbitrage Trading, Tailored for Market-Neutral Funds
Jun 3, 2024 12:00PM Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly
View Older Stories